Stay updated on Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision updated from v3.6.2 to v3.6.3 on the page. This represents a minor page update (likely for fixes or formatting) with no apparent changes to study details.
    Difference
    0.1%
    Check dated 2026-07-04T13:30:06.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.0 to v3.6.2, indicating a new deployment of the Study Details page. This likely reflects minor updates or fixes to formatting or backend data without altering the displayed study information.
    Difference
    0.1%
    Check dated 2026-06-27T05:59:00.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    Recruitment status and new help sections were added, including How to Read a Study Record, Common Questions, and How to Join a Study; the Intervention/Treatment heading was added, while some related topics and the Lung Cancer label were removed, and the page was updated to revision v3.6.0.
    Difference
    0.6%
    Check dated 2026-06-13T01:12:28.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    A Lung cancer topic tag and a related MedlinePlus Genetics link were added, and the revision version was updated from v3.5.4 to v3.5.5.
    Difference
    0.2%
    Check dated 2026-06-05T21:51:54.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Removed the 'Lung cancer' keyword and the 'MedlinePlus Genetics' entry from the related topics section. The related topics header was also removed, reducing cross-links to external resources.
    Difference
    0.2%
    Check dated 2026-05-30T00:52:06.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Expanded the MedlinePlus related topics to include Lung cancer and MedlinePlus Genetics, broadening the educational resources linked from the study page.
    Difference
    0.2%
    Check dated 2026-05-21T21:48:24.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page.